Pharma budget freeze hits Doximity — Q4 revenue guided at just +4% growth
Mar 2026
▼
Watch
16 of top 20 pharma companies signed MFN agreements, causing delayed bookings. Q4 guided at +4% vs +23% in Q2. Moat intact: 117% revenue retention, #1 ROIC of 47 peers. All AI revenue excluded from guidance — low bar that could be materially beaten.
Class action filed — channel destocking hits core shakes revenue for first time
Feb 2026
▼
Caution
Premier Protein RTD market share fell 500bps to 25%. Securities class action filed. Core shakes revenue turned negative for first time. Brand remains #1 in RTD protein — channel reset, not collapse. GLP-1 tailwind structural. Two clean quarters needed before re-entry.
Only public ground lease REIT at 0.41× book — $220M new originations in Q2 2025
Mar 2026
▼
Income
Safehold closed $220M in new originations in Q2 2025. Net margin improved from 29.3% → 30.4%. Stock at 0.41× book — P/E #1 of 17 REIT peers — because rising rates compressed long-duration lease values. The 5.23% dividend pays while waiting for rate-driven re-rating.